A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.
about
Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future ResearchPreventing Infections in Sickle Cell Disease: The Unfinished Business.Presentations of sickle cell disease patients to hospital in Ghana: key findings from a preliminary study at Volta Regional Hospital.Sickle cell disease.Sickle Cell Disease Clinical Trials and Phenotypes
P2860
A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@ast
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@en
type
label
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@ast
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@en
prefLabel
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@ast
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@en
P2093
P2860
P50
P921
P356
P1476
A Randomized Trial to Compare ...... ents With Sickle Cell Disease.
@en
P2093
Ayotade Ojuawo
Benedict Olorunsola
Jean-René Kiechel
Kolade Ernest
Muna Affara
Olugbenga Mokuolu
Peter Omefe
Rasaq Olaosebikan
Rukayat Murtala
Surajudeen Bello
P2860
P304
P356
10.1093/INFDIS/JIV093
P407
P50
P577
2015-02-20T00:00:00Z